ID   UBP3_HUMAN              Reviewed;         520 AA.
AC   Q9Y6I4; B4DVU5; F5H1A6; Q8WVD0;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   02-SEP-2008, sequence version 2.
DT   15-MAR-2017, entry version 147.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 3;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 3;
DE   AltName: Full=Ubiquitin thioesterase 3;
DE   AltName: Full=Ubiquitin-specific-processing protease 3;
GN   Name=USP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10480896; DOI=10.1074/jbc.274.38.26878;
RA   Sloper-Mould K.E., Eyre H.J., Wang X.-W., Sutherland G.R., Baker R.T.;
RT   "Characterization and chromosomal localization of USP3, a novel human
RT   ubiquitin-specific protease.";
RL   J. Biol. Chem. 274:26878-26884(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, INTERACTION WITH H2A, SUBCELLULAR LOCATION, MUTAGENESIS OF
RP   HIS-56 AND CYS-168, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17980597; DOI=10.1016/j.cub.2007.10.034;
RA   Nicassio F., Corrado N., Vissers J.H., Areces L.B., Bergink S.,
RA   Marteijn J.A., Geverts B., Houtsmuller A.B., Vermeulen W.,
RA   Di Fiore P.P., Citterio E.;
RT   "Human USP3 is a chromatin modifier required for S phase progression
RT   and genome stability.";
RL   Curr. Biol. 17:1972-1977(2007).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
CC   -!- FUNCTION: Hydrolase that deubiquitinates monoubiquitinated target
CC       proteins such as histone H2A and H2B. Required for proper
CC       progression through S phase and subsequent mitotic entry. May
CC       regulate the DNA damage response (DDR) checkpoint through
CC       deubiquitination of H2A at DNA damage sites. Associates with the
CC       chromatin. {ECO:0000269|PubMed:17980597}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC   -!- SUBUNIT: Interacts (via UBP-type domain) with H2A; the interaction
CC       is less efficient than with monoubiquitinated H2A.
CC       {ECO:0000269|PubMed:17980597}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17980597}.
CC       Note=Localizes preferentially with monoubiquitinated H2A to
CC       chromatin.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y6I4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y6I4-2; Sequence=VSP_044712;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues examined, with
CC       strongest expression in pancreas.
CC   -!- DOMAIN: Both protease activity and an intact zinc finger are
CC       required for H2A monodeubiquitination.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. USP3 subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD42992.1; Type=Frameshift; Positions=265, 274, 299; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF073344; AAD42992.1; ALT_FRAME; mRNA.
DR   EMBL; BT007269; AAP35933.1; -; mRNA.
DR   EMBL; AK301236; BAG62807.1; -; mRNA.
DR   EMBL; AC007950; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC118274; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471082; EAW77651.1; -; Genomic_DNA.
DR   EMBL; BC018113; AAH18113.1; -; mRNA.
DR   EMBL; BC065300; AAH65300.1; -; mRNA.
DR   EMBL; BC107137; AAI07138.1; -; mRNA.
DR   EMBL; BC107138; AAI07139.1; -; mRNA.
DR   CCDS; CCDS32265.1; -. [Q9Y6I4-1]
DR   CCDS; CCDS58370.1; -. [Q9Y6I4-2]
DR   RefSeq; NP_001243631.1; NM_001256702.1. [Q9Y6I4-2]
DR   RefSeq; NP_006528.2; NM_006537.3. [Q9Y6I4-1]
DR   UniGene; Hs.458499; -.
DR   ProteinModelPortal; Q9Y6I4; -.
DR   SMR; Q9Y6I4; -.
DR   BioGrid; 115285; 37.
DR   DIP; DIP-53585N; -.
DR   IntAct; Q9Y6I4; 20.
DR   STRING; 9606.ENSP00000369681; -.
DR   MEROPS; C19.026; -.
DR   iPTMnet; Q9Y6I4; -.
DR   PhosphoSitePlus; Q9Y6I4; -.
DR   BioMuta; USP3; -.
DR   DMDM; 205371844; -.
DR   EPD; Q9Y6I4; -.
DR   MaxQB; Q9Y6I4; -.
DR   PaxDb; Q9Y6I4; -.
DR   PeptideAtlas; Q9Y6I4; -.
DR   PRIDE; Q9Y6I4; -.
DR   DNASU; 9960; -.
DR   Ensembl; ENST00000380324; ENSP00000369681; ENSG00000140455. [Q9Y6I4-1]
DR   Ensembl; ENST00000540797; ENSP00000445828; ENSG00000140455. [Q9Y6I4-2]
DR   GeneID; 9960; -.
DR   KEGG; hsa:9960; -.
DR   UCSC; uc002amf.5; human. [Q9Y6I4-1]
DR   CTD; 9960; -.
DR   DisGeNET; 9960; -.
DR   GeneCards; USP3; -.
DR   H-InvDB; HIX0012328; -.
DR   HGNC; HGNC:12626; USP3.
DR   HPA; HPA053275; -.
DR   HPA; HPA060513; -.
DR   MIM; 604728; gene.
DR   neXtProt; NX_Q9Y6I4; -.
DR   OpenTargets; ENSG00000140455; -.
DR   PharmGKB; PA37251; -.
DR   eggNOG; KOG1867; Eukaryota.
DR   eggNOG; ENOG410XQQ0; LUCA.
DR   GeneTree; ENSGT00870000136393; -.
DR   HOGENOM; HOG000231498; -.
DR   HOVERGEN; HBG103589; -.
DR   InParanoid; Q9Y6I4; -.
DR   KO; K11986; -.
DR   OMA; DETELYM; -.
DR   OrthoDB; EOG091G05JL; -.
DR   PhylomeDB; Q9Y6I4; -.
DR   TreeFam; TF315281; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP3; human.
DR   GenomeRNAi; 9960; -.
DR   PRO; PR:Q9Y6I4; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140455; -.
DR   CleanEx; HS_USP3; -.
DR   ExpressionAtlas; Q9Y6I4; baseline and differential.
DR   Genevisible; Q9Y6I4; HS.
DR   GO; GO:0070938; C:contractile ring; IDA:HPA.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0001046; F:core promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0042393; F:histone binding; IPI:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; TAS:ProtInc.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006281; P:DNA repair; IMP:UniProtKB.
DR   GO; GO:0016578; P:histone deubiquitination; IDA:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0031647; P:regulation of protein stability; IDA:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR001607; Znf_UBP.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF02148; zf-UBP; 1.
DR   SMART; SM00290; ZnF_UBP; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
DR   PROSITE; PS50271; ZF_UBP; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell cycle; Chromatin regulator;
KW   Complete proteome; DNA damage; Hydrolase; Metal-binding; Nucleus;
KW   Polymorphism; Protease; Reference proteome; Thiol protease;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    520       Ubiquitin carboxyl-terminal hydrolase 3.
FT                                /FTId=PRO_0000080619.
FT   DOMAIN      159    511       USP.
FT   ZN_FING      27    104       UBP-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00502}.
FT   ACT_SITE    168    168       Nucleophile. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   ACT_SITE    471    471       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   VAR_SEQ      51     95       RYVNGHAKKHYEDAQVPLTNHKKSEKQDKVQHTVCMDCSSY
FT                                STYC -> S (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044712.
FT   VARIANT     360    360       P -> T (in dbSNP:rs34776764).
FT                                /FTId=VAR_051521.
FT   MUTAGEN      56     56       H->A: Does not reduce monoubiquitinated
FT                                H2A and H2B stability. Interaction with
FT                                monoubiquitinated H2A is strongly
FT                                inhibited. {ECO:0000269|PubMed:17980597}.
FT   MUTAGEN     168    168       C->S: Does not reduce H2A stability.
FT                                Interacts more strongly with
FT                                monoubiquitinated H2A than with
FT                                nonubiquitinated H2A. Its nuclear
FT                                localization to chromatin is enhanced.
FT                                {ECO:0000269|PubMed:17980597}.
FT   CONFLICT    439    439       C -> W (in Ref. 1; AAD42992).
FT                                {ECO:0000305}.
FT   CONFLICT    473    473       T -> I (in Ref. 3; BAG62807).
FT                                {ECO:0000305}.
SQ   SEQUENCE   520 AA;  58897 MW;  AC27FE9BD0438893 CRC64;
     MECPHLSSSV CIAPDSAKFP NGSPSSWCCS VCRSNKSPWV CLTCSSVHCG RYVNGHAKKH
     YEDAQVPLTN HKKSEKQDKV QHTVCMDCSS YSTYCYRCDD FVVNDTKLGL VQKVREHLQN
     LENSAFTADR HKKRKLLENS TLNSKLLKVN GSTTAICATG LRNLGNTCFM NAILQSLSNI
     EQFCCYFKEL PAVELRNGKT AGRRTYHTRS QGDNNVSLVE EFRKTLCALW QGSQTAFSPE
     SLFYVVWKIM PNFRGYQQQD AHEFMRYLLD HLHLELQGGF NGVSRSAILQ ENSTLSASNK
     CCINGASTVV TAIFGGILQN EVNCLICGTE SRKFDPFLDL SLDIPSQFRS KRSKNQENGP
     VCSLRDCLRS FTDLEELDET ELYMCHKCKK KQKSTKKFWI QKLPKVLCLH LKRFHWTAYL
     RNKVDTYVEF PLRGLDMKCY LLEPENSGPE SCLYDLAAVV VHHGSGVGSG HYTAYATHEG
     RWFHFNDSTV TLTDEETVVK AKAYILFYVE HQAKAGSDKL
//
